News

November 11, 2020

Targeted therapies developed to reduce lung fibrosis

Philip S. Low, Purdue’s Ralph C. Corley Distinguished Professor of Chemistry and Presidential Scholar for Drug Discovery, has led a team to develop two targeted therapies for people with idiopathic pulmonary fibrosis (IPF).

Read More

October 22, 2020

Technology shines the light on ovarian cancer treatments

Scientists estimate that nearly 60% of all cancer patients do not respond effectively to chemotherapy treatments or experience toxic and sometimes deadly side effects.A Purdue University scientist is working to use simple LED light to help determine if certain chemotherapy options will work for specific patients.

Read More